Summary
The ratio of albumin in cerebrospinal fluid (CSF) to serum may serve as an index of the integrity of the blood-CSF barrier, with increases in this ratio indicating increased permeability. The ratio of immunoglobulin G (IgG) in CSF to serum (divided by the albumin ratio to correct for variance in blood-CSF permeability) represents an index of the endogenous production of IgG in the central nervous system (CNS), with increases reflecting a possible infectious and/or autoimmune process stimulating central IgG synthesis. We analyzed simultaneously collected CSF and serum samples from 46 schizophrenic subjects, 8 of whom were studied both on and off neuroleptic treatment, and samples from 20 normal controls. The data indicated increases in CSF/ serum albumin ratios or CSF/serum IgG indices in 22% and 20%, respectively, of the schizophrenic patients. Only 3 patients showed elevations in both indices. Comparison of values on and off neuroleptics indicated no significant effect of neuroleptics on these indices.
Similar content being viewed by others
References
Ahokas A, Koskiniemi M, Vaheri A, Rimon R (1985) Altered white cell count, protein concentration and oligoclonal IgG bands in the cerebrospinal fluid of many patients with acute psychiatric disorders. Neuropsychobiology 14: 1–4
American Psychiatric Association, Committee on Nomenclature and Statistics (1980) Diagnostic and statistical manual of mental disorders, 3rd ed. Washington, D.C.
Axelsson R, Martensson E, Alling C (1982) Impairment of the blood-brain barrier as an aetiological factor in paranoid psychosis. Br J Psychiatry 141: 273–281
Bauer K, Kornhuber J (1987) Blood-cerebrospinal fluid in schizophrenic patients. Eur Arch Psychiatr Neurol Sci 236: 257–259
Bock E (1978) Immunoglobulins, prealbumin, transferrin, albumin, and alpha2-macroglobulin in cerebrospinal fluid and serum in schizophrenic patients. Birth Defects 14: 283–295
Bock E, Rafaelson OJ (1974) Schizophrenia: proteins in blood and cerebrospinal fluid. Dan Med Bull 21: 93–105
Braun U, Braun G, Sargent T (1980) Changes in the blood-brain barrier permeability resulting from d-amphetamine, 6-hydroxydopamine and pimozide measured by a new technique. Experientia 36: 207–209
Bruetsch VL, Bahr MA, Skobba JS, Dieter VJ (1942) The group of dementia praecox patients with an increase of the protein content of the cerebrospinal fluid. J Nerv Ment Dis 95: 669–679
Burns EM, Nasrallah HA, Kathol M, Kruckeberg TW, Coffman JA (1987) Right vs. left hemispheric blood-brain barrier permeability in schizophrenia: a dynamic computed tomographic study. Psychiatry Res 22: 229–241
Caroscio JT, Kochwa S, Sacks H, Cohen JA, Yahr MD (1983) Quantitative CSF IgG measurements in multiple sclerosis and other neurological diseases. Arch Neurol 40: 409–413
Christenson RH, Russel ME, Bell YL (1988) Immunoassays for immunoglobulin G (IgG) in cerebrospinal fluid (CSF) compared. Clin Chem 34: 1158
Cutler RWP (1980) Neurochemical aspects of blood-brain-cerebrospinal fluid barriers. In: Wood JH (ed) Neurobiology of cerebrospinal fluid. Plenum, New York, pp 41–51
DeLisi LE, Crow TJ (1986) Is schizophrenia a viral or immunologic disorder? Psychiatr Clin North Am 9: 115–132
Dysken M, Patlak CS, Dobben GD, Pettigrew KD, Bartko JJ, Burns EM, Davis J, Regier DA (1987) Rapid dynamic CT scanning to distinguish schizophrenic from normal subjects. Psychiatry Res 20: 165–175
Felgenhauer K (1974) Protein size and cerebrospinal fluid composition. Klin Wochenschr 52: 1158–1164
Ganrot K, Laurell CB (1974) Measurement of IgG and albumin content of cerebrospinal fluid, and its interpretation. Clin Chem 20: 571–573
Goldstein GW, Betz AL (1986) The blood-brain barrier. Sci Am 255: 74–83
Harrington MG, Merril CR, Torrey EF (1985) Differences in cerebrospinal fluid proteins between patients with schizophrenia and normal persons. Clin Chem 31: 722–726
Killingsworth LM (1982) Clinical applications of protein determinations in biological fluids other than blood. Clin Chem 28: 1093–1102
Kirch DG, Kaufmann CA, Papadopolous NM, Martin B, Weinberger DR (1985) Abnormal cerebrospinal fluid protein indices in schizophrenia. Biol Psychiatry 20: 1039–1046
Knight JG (1982) Dopamine-receptor-stimulating autoantibodies: a possible cause of schizophrenia. Lancet: 1073–1076
Lampson LA (1987) Molecular bases of the immune response to neural antigens. TINS 10: 211–216
Link H, Tibbling G (1977) Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis. Scand J Clin Lab Invest 37: 397–401
Papadopoulos NM, Costello R, Kay AD, Cutler NR, Rapaport SI (1984) Combined immunochemical and electrophoretic determinations of proteins in paired serum and cerebrospinal fluid samples. Clin Chem 30: 1814–1816
Papadopoulos NM, McFarlin DE, Patranas NJ, McFarland HF, Costello R (1987) A comparison between chemical analysis and magnetic resonance imaging with the clinical diagnosis of multiple sclerosis. Am J Clin Pathol 88: 365–368
Pearson EK (1973) Study of cerebrospinal fluid in schizophrenics: a review of the literature. Psychopharmacol Bull 9: 59–62
Pert CB, Knight JC, Laing P, Markwell MAK (1988) Scenarios for a viral etiology of schizophrenia. Schizophr Bull 14: 243–247
Preskorn SH, Irwin GH, Simpson S, Friesen D, Rinne J, Jerkovich G (1981) Medical therapies for mood disorders alter the blood-brain barrier. Science 213: 469–471
Reese TS, Karnovsky MJ (1967) Five structural localizations of a blood-brain barrier to exogeneous peroxidase. J Cell Biol 34: 207–217
Roos RP, Davis K, Meltzer HY (1985) Immunoglobulin studies in patients with psychiatric diseases. Arch Gen Psychiatry 42: 124–128
Schliep G, Felgenhauer K (1978) Serum-CSF protein gradients, the blood-CSF barrier and local immune response. J Neurol 218: 77–96
Shapiro WR (1988) Cerebrospinal fluid circulation and the blood-brain barrier. Ann NY Acad Sci 531: 9–14
Shelton RC, Karson CN, Doran AR, Pickar D, Bigelow LB, Weinberger DR (1988) Cerebral structural pathology in schizophrenia: evidence for a selective prefrontal cortical deficit. Am J Psychiatry 145: 154–163
Stevens JR (1988) Schizophrenia and multiple sclerosis. Schizophr Bull 14: 231–241
Stevens JR, Papadopoulos NM, Resnick M (1990) Oligoclonal bands in acute schizophrenia: a negative search. Acta Psychiatr Scand 81: 262–264
Synek W, Reuben JR (1976) The ventricular brain ratio using planimetric measurement of EMI scans. Br J Radiol 49: 233–237
Tibbling G, Link H, Ohman S (1977) Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest 37: 385–390
Torrey EF, Kaufmann CA (1986) Schizophrenia and neuroviruses. In: Nasrallah HA, Weinberger DR (eds) The neurology of schizophrenia. Elsevier, Amsterdam, pp 361–376
Torrey EF, Albrecht P, Behr DE (1985) Permeability of the blood-brain barrier in psychiatric patients. Am J Psychiatry 142: 657–658
Tourtellotte WW, Potvin AR, Fleming JO, Murphy KN, Levy K, Syndulko K, Potvin JH (1980) Multiple sclerosis: measurement and validation of central nervous system IgG synthesis rate. Neurology 30: 240–244
van Kammen DP, Sternberg DE (1980) Cerebrospinal fluid studies in schizophrenia. In: Wood JH (ed) Neurobiology of cerebrospinal fluid. Plenum, New York, pp 719–742
Winfield JB, Shaw M, Silverman LM, Eisenberg RA, Wilson HA, Koffler D (1983) Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunction. Am J Med 74: 837–844
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kirch, D.G., Alexander, R.C., Suddath, R.L. et al. Blood-CSF barrier permeability and central nervous system immunoglobulin G in schizophrenia. J. Neural Transmission 89, 219–232 (1992). https://doi.org/10.1007/BF01250674
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01250674